版本:
中国

BRIEF-Prospect Park Capital says will not receive milestone payment held onto upon sale of interest in IOI

March 29 Prospect Park Capital Corp

* Says advised by Serenity Pharmaceuticals co will not receive milestone payment which it held onto upon sale of interest in IOI

* Says prospect park's final return on its investment in IOI remains at 8%.

* Will not receive payment in light of Allergan exercising unilateral right to terminate license, transfer, development agreement with Serenity Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐